Review




Structured Review

Mimetics bh3 mimetics abt 737
a. Gene ontology analysis of differentially expressed genes of HAP-1 cells after 24 h treatment with 50 nM of NoA or DMSO vehicle control. b. Schematic of mitochondrial apoptosis regulation by BCL-2 family members. Chronic cellular stress <t>BH3-only</t> proteins upregulation antagonize pro-survival BCL-2 members and activate BAX/BAK, resulting in mitochondrial outer membrane permeabilization and apoptosis. c. Heatmap showing regulation of canonical ATF4 target genes extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. d. Heatmap showing regulation of canonical JUN target genes extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. e. Heatmap showing regulation of pro-apoptotic BH-3 proteins extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. f. Western blot analysis of HAP-1 WT cells treated with 50 nM NoA. Cells were harvested at 0, 3, 6, 12 and 24 h after treatment, and protein lysates were probed with the indicated antibodies. g. Nalm-6 WT and KO clones were treated with 12, 25 and 50 nM of NoA. Annexin V surface binding and Propidium Iodide uptake was measured after 72 h to assess viability of the cells. Bar plots show mean ± SD of three biological replicates. Legend: AV−/PI− = live cells, AV+/PI− = early apoptosis, AV+/PI+ and AV−/PI+ = late apoptosis. Statistical significance was determined using a two-way ANOVA with Bonferroni correction for multiple comparisons, comparing percentages of live cells of corresponding concentrations between WT and KO clones. * P < 0.05, ** P < 0.005 h. Western blot analysis of Nalm-6 and HCT-116 WT cells treated with 50 nM NoA. Cells were harvested at 0, 12, 24 and 36 h after NoA treatment and protein lysates probed with indicated antibodies. MCL-1 OMM refers to the full-length, anti-apoptotic isoform MCL-1.
Bh3 Mimetics Abt 737, supplied by Mimetics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bh3+mimetics+abt-737/bh3+mimetics/bio_rxiv__64898__2026__03__27__714872-5-20-21
Average 86 stars, based on 1 article reviews
bh3 mimetics abt 737 - by Bioz Stars, 2026-10
86/100 stars

Images

1) Product Images from "Inhibition of V-ATPase function drives apoptosis via GCN1/GCN2 kinase signaling"

Article Title: Inhibition of V-ATPase function drives apoptosis via GCN1/GCN2 kinase signaling

Journal: bioRxiv

doi: 10.64898/2026.03.27.714872

a. Gene ontology analysis of differentially expressed genes of HAP-1 cells after 24 h treatment with 50 nM of NoA or DMSO vehicle control. b. Schematic of mitochondrial apoptosis regulation by BCL-2 family members. Chronic cellular stress BH3-only proteins upregulation antagonize pro-survival BCL-2 members and activate BAX/BAK, resulting in mitochondrial outer membrane permeabilization and apoptosis. c. Heatmap showing regulation of canonical ATF4 target genes extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. d. Heatmap showing regulation of canonical JUN target genes extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. e. Heatmap showing regulation of pro-apoptotic BH-3 proteins extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. f. Western blot analysis of HAP-1 WT cells treated with 50 nM NoA. Cells were harvested at 0, 3, 6, 12 and 24 h after treatment, and protein lysates were probed with the indicated antibodies. g. Nalm-6 WT and KO clones were treated with 12, 25 and 50 nM of NoA. Annexin V surface binding and Propidium Iodide uptake was measured after 72 h to assess viability of the cells. Bar plots show mean ± SD of three biological replicates. Legend: AV−/PI− = live cells, AV+/PI− = early apoptosis, AV+/PI+ and AV−/PI+ = late apoptosis. Statistical significance was determined using a two-way ANOVA with Bonferroni correction for multiple comparisons, comparing percentages of live cells of corresponding concentrations between WT and KO clones. * P < 0.05, ** P < 0.005 h. Western blot analysis of Nalm-6 and HCT-116 WT cells treated with 50 nM NoA. Cells were harvested at 0, 12, 24 and 36 h after NoA treatment and protein lysates probed with indicated antibodies. MCL-1 OMM refers to the full-length, anti-apoptotic isoform MCL-1.
Figure Legend Snippet: a. Gene ontology analysis of differentially expressed genes of HAP-1 cells after 24 h treatment with 50 nM of NoA or DMSO vehicle control. b. Schematic of mitochondrial apoptosis regulation by BCL-2 family members. Chronic cellular stress BH3-only proteins upregulation antagonize pro-survival BCL-2 members and activate BAX/BAK, resulting in mitochondrial outer membrane permeabilization and apoptosis. c. Heatmap showing regulation of canonical ATF4 target genes extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. d. Heatmap showing regulation of canonical JUN target genes extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. e. Heatmap showing regulation of pro-apoptotic BH-3 proteins extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. f. Western blot analysis of HAP-1 WT cells treated with 50 nM NoA. Cells were harvested at 0, 3, 6, 12 and 24 h after treatment, and protein lysates were probed with the indicated antibodies. g. Nalm-6 WT and KO clones were treated with 12, 25 and 50 nM of NoA. Annexin V surface binding and Propidium Iodide uptake was measured after 72 h to assess viability of the cells. Bar plots show mean ± SD of three biological replicates. Legend: AV−/PI− = live cells, AV+/PI− = early apoptosis, AV+/PI+ and AV−/PI+ = late apoptosis. Statistical significance was determined using a two-way ANOVA with Bonferroni correction for multiple comparisons, comparing percentages of live cells of corresponding concentrations between WT and KO clones. * P < 0.05, ** P < 0.005 h. Western blot analysis of Nalm-6 and HCT-116 WT cells treated with 50 nM NoA. Cells were harvested at 0, 12, 24 and 36 h after NoA treatment and protein lysates probed with indicated antibodies. MCL-1 OMM refers to the full-length, anti-apoptotic isoform MCL-1.

Techniques Used: Control, Membrane, RNA Sequencing, Expressing, Western Blot, Clone Assay, Binding Assay

a. Bottom: Representative cell cycle profiles of HAP-1 WT and BB dKO cells after exposure to 12.5, 25 and 50 nM of NoA. Right: Ǫuantification of the SubG1 population represented as bar graphs, showing means and SD of N=3 biological replicates. Statistical significance was determined using a two-way ANOVA with Bonferroni correction for multiple comparisons, comparing SubG1 percentages of corresponding concentrations of WT with BBdKO cells at every time point. **** P < 0.0001 b. HAP-1 WT and HAP-1 BB dKO KO cells were treated with 12.5, 25 and 50 nM of BafA1. Annexin V surface binding and Propidium Iodide uptake was measured after 48 and 72 h to assess viability of the cells. Bar plots show mean ± SD of three biological replicates. Legend: AV−/PI− = live cells, AV+/PI− = early apoptosis, AV+/PI+ and AV−/PI+ = late apoptosis. Statistical significance was determined using a two-way ANOVA with Bonferroni correction for multiple comparisons, comparing percentages of live cells of corresponding concentrations between WT and BB dKO cells at every time point. **** P < 0.0001. c. WB analysis of HAP-1 WT, GCN1 KO, and GCN2 KO cells treated with NoA or BafA1 (25 or 50 nM) for 24 h. Cell lysates were probed for the indicated proteins. d. HAP-1 WT and GCN1 KO cells were treated with BafA1 (6.25, 12.5, 25, or 50 nM). HAP-1 WT cells were treated either with BafA1 alone or in combination with the GCN2 inhibitor GCN2iB (10 μM). Annexin V surface binding and propidium iodide (PI) uptake were measured after 48 and 72 h to assess cell viability. Bar plots represent mean ± SD of three biological replicates. Legend: AV−/PI−, live cells; AV+/PI−, early apoptosis; AV+/PI+ and AV−/PI+, late apoptosis. Statistical significance was determined by two-way ANOVA with Bonferroni correction for multiple comparisons, comparing percentages of live cells at corresponding concentrations between WT and GCN1 KO cells or WT cells co-treated with GCN2iB at each time point. ** P < 0.01, *** P < 0.001, ** P < 0.0001. e. HCT-116 WT and Octa KO clones were treated with 12.5, 25 and 5 0nM of BafA1. Annexin V surface binding and Propidium Iodide uptake was measured after 24, 48 and 72 h to assess cell viability. Bar plots show mean ± SD of three biological replicates. Legend: AV−/PI− = live cells, AV+/PI− = early apoptosis, AV+/PI+ and AV−/PI+ = late apoptosis. Statistical significance was determined using a two-way ANOVA with Bonferroni correction for multiple comparisons, comparing percentages of live cells of corresponding concentrations between WT and Octa KO clones. * P < 0.015, ** P < 0.004, *** P < 0.001, **** P < 0.0001 f. HAP-1 WT cells were treated with indicated V-ATPase inhibitors (25 nM) or ABT-737 (1 μM) alone or in combination for 24 h. Viability was assessed by Annexin V surface binding and Propidium Iodide uptake. Viable fraction was defined as double negative cells and is depicted as mean ± SD of three biological replicates. g. Dot plot showing synergy scores for combinations of V-ATPase inhibitors with BH3 mimetics (ABT-737 and ABT-199). Synergy scores were calculated using the SynergyFinder web tool based on concentration matrices of two biological replicates. Cell viability was defined as the fraction of Annexin V−/PI− (double-negative) cells, representing live cells. h. Proposed mechanism for V-ATPase inhibition induced cell death
Figure Legend Snippet: a. Bottom: Representative cell cycle profiles of HAP-1 WT and BB dKO cells after exposure to 12.5, 25 and 50 nM of NoA. Right: Ǫuantification of the SubG1 population represented as bar graphs, showing means and SD of N=3 biological replicates. Statistical significance was determined using a two-way ANOVA with Bonferroni correction for multiple comparisons, comparing SubG1 percentages of corresponding concentrations of WT with BBdKO cells at every time point. **** P < 0.0001 b. HAP-1 WT and HAP-1 BB dKO KO cells were treated with 12.5, 25 and 50 nM of BafA1. Annexin V surface binding and Propidium Iodide uptake was measured after 48 and 72 h to assess viability of the cells. Bar plots show mean ± SD of three biological replicates. Legend: AV−/PI− = live cells, AV+/PI− = early apoptosis, AV+/PI+ and AV−/PI+ = late apoptosis. Statistical significance was determined using a two-way ANOVA with Bonferroni correction for multiple comparisons, comparing percentages of live cells of corresponding concentrations between WT and BB dKO cells at every time point. **** P < 0.0001. c. WB analysis of HAP-1 WT, GCN1 KO, and GCN2 KO cells treated with NoA or BafA1 (25 or 50 nM) for 24 h. Cell lysates were probed for the indicated proteins. d. HAP-1 WT and GCN1 KO cells were treated with BafA1 (6.25, 12.5, 25, or 50 nM). HAP-1 WT cells were treated either with BafA1 alone or in combination with the GCN2 inhibitor GCN2iB (10 μM). Annexin V surface binding and propidium iodide (PI) uptake were measured after 48 and 72 h to assess cell viability. Bar plots represent mean ± SD of three biological replicates. Legend: AV−/PI−, live cells; AV+/PI−, early apoptosis; AV+/PI+ and AV−/PI+, late apoptosis. Statistical significance was determined by two-way ANOVA with Bonferroni correction for multiple comparisons, comparing percentages of live cells at corresponding concentrations between WT and GCN1 KO cells or WT cells co-treated with GCN2iB at each time point. ** P < 0.01, *** P < 0.001, ** P < 0.0001. e. HCT-116 WT and Octa KO clones were treated with 12.5, 25 and 5 0nM of BafA1. Annexin V surface binding and Propidium Iodide uptake was measured after 24, 48 and 72 h to assess cell viability. Bar plots show mean ± SD of three biological replicates. Legend: AV−/PI− = live cells, AV+/PI− = early apoptosis, AV+/PI+ and AV−/PI+ = late apoptosis. Statistical significance was determined using a two-way ANOVA with Bonferroni correction for multiple comparisons, comparing percentages of live cells of corresponding concentrations between WT and Octa KO clones. * P < 0.015, ** P < 0.004, *** P < 0.001, **** P < 0.0001 f. HAP-1 WT cells were treated with indicated V-ATPase inhibitors (25 nM) or ABT-737 (1 μM) alone or in combination for 24 h. Viability was assessed by Annexin V surface binding and Propidium Iodide uptake. Viable fraction was defined as double negative cells and is depicted as mean ± SD of three biological replicates. g. Dot plot showing synergy scores for combinations of V-ATPase inhibitors with BH3 mimetics (ABT-737 and ABT-199). Synergy scores were calculated using the SynergyFinder web tool based on concentration matrices of two biological replicates. Cell viability was defined as the fraction of Annexin V−/PI− (double-negative) cells, representing live cells. h. Proposed mechanism for V-ATPase inhibition induced cell death

Techniques Used: Binding Assay, Clone Assay, Concentration Assay, Inhibition

Related Articles

Functional Assay:

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins ( K–S).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: In contrast, the BH3 mimetics ABT-737 and navitoclax were cytotoxic and did not confer functional benefits to eSCs.

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration ( E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect ( E).

Article Title: Differential regulation of BAX and BAK apoptotic activity revealed by small molecules
Article Snippet: In line with this, WEHI-3773 enabled long-term clonogenic survival of BAK −/− HeLa and BAK −/− HCT116 cell lines treated with BH3 mimetics ABT-737 and MCL-1 inhibitor S63845, whereas caspase inhibition with quinoline-Val-Asp-difluorophenoxymethylketone (QVD-OPh) did not ( , and fig. S3, C and D).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration (Figure 4E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect (Figure 4E).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins (Figure 5K–S).

Migration:

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins ( K–S).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: In contrast, the BH3 mimetics ABT-737 and navitoclax were cytotoxic and did not confer functional benefits to eSCs.

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration ( E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect ( E).

Article Title: Differential regulation of BAX and BAK apoptotic activity revealed by small molecules
Article Snippet: In line with this, WEHI-3773 enabled long-term clonogenic survival of BAK −/− HeLa and BAK −/− HCT116 cell lines treated with BH3 mimetics ABT-737 and MCL-1 inhibitor S63845, whereas caspase inhibition with quinoline-Val-Asp-difluorophenoxymethylketone (QVD-OPh) did not ( , and fig. S3, C and D).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration (Figure 4E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect (Figure 4E).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins (Figure 5K–S).

Expressing:

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins ( K–S).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: In contrast, the BH3 mimetics ABT-737 and navitoclax were cytotoxic and did not confer functional benefits to eSCs.

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration ( E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect ( E).

Article Title: Differential regulation of BAX and BAK apoptotic activity revealed by small molecules
Article Snippet: In line with this, WEHI-3773 enabled long-term clonogenic survival of BAK −/− HeLa and BAK −/− HCT116 cell lines treated with BH3 mimetics ABT-737 and MCL-1 inhibitor S63845, whereas caspase inhibition with quinoline-Val-Asp-difluorophenoxymethylketone (QVD-OPh) did not ( , and fig. S3, C and D).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration (Figure 4E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect (Figure 4E).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins (Figure 5K–S).

Inhibition:

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins ( K–S).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: In contrast, the BH3 mimetics ABT-737 and navitoclax were cytotoxic and did not confer functional benefits to eSCs.

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration ( E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect ( E).

Article Title: Differential regulation of BAX and BAK apoptotic activity revealed by small molecules
Article Snippet: In line with this, WEHI-3773 enabled long-term clonogenic survival of BAK −/− HeLa and BAK −/− HCT116 cell lines treated with BH3 mimetics ABT-737 and MCL-1 inhibitor S63845, whereas caspase inhibition with quinoline-Val-Asp-difluorophenoxymethylketone (QVD-OPh) did not ( , and fig. S3, C and D).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration (Figure 4E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect (Figure 4E).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins (Figure 5K–S).

Selection:

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins ( K–S).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: In contrast, the BH3 mimetics ABT-737 and navitoclax were cytotoxic and did not confer functional benefits to eSCs.

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration ( E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect ( E).

Article Title: Differential regulation of BAX and BAK apoptotic activity revealed by small molecules
Article Snippet: In line with this, WEHI-3773 enabled long-term clonogenic survival of BAK −/− HeLa and BAK −/− HCT116 cell lines treated with BH3 mimetics ABT-737 and MCL-1 inhibitor S63845, whereas caspase inhibition with quinoline-Val-Asp-difluorophenoxymethylketone (QVD-OPh) did not ( , and fig. S3, C and D).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration (Figure 4E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect (Figure 4E).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins (Figure 5K–S).

Fluorescence:

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins ( K–S).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: In contrast, the BH3 mimetics ABT-737 and navitoclax were cytotoxic and did not confer functional benefits to eSCs.

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration ( E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect ( E).

Article Title: Differential regulation of BAX and BAK apoptotic activity revealed by small molecules
Article Snippet: In line with this, WEHI-3773 enabled long-term clonogenic survival of BAK −/− HeLa and BAK −/− HCT116 cell lines treated with BH3 mimetics ABT-737 and MCL-1 inhibitor S63845, whereas caspase inhibition with quinoline-Val-Asp-difluorophenoxymethylketone (QVD-OPh) did not ( , and fig. S3, C and D).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration (Figure 4E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect (Figure 4E).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins (Figure 5K–S).

Control:

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins ( K–S).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: In contrast, the BH3 mimetics ABT-737 and navitoclax were cytotoxic and did not confer functional benefits to eSCs.

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration ( E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect ( E).

Article Title: Differential regulation of BAX and BAK apoptotic activity revealed by small molecules
Article Snippet: In line with this, WEHI-3773 enabled long-term clonogenic survival of BAK −/− HeLa and BAK −/− HCT116 cell lines treated with BH3 mimetics ABT-737 and MCL-1 inhibitor S63845, whereas caspase inhibition with quinoline-Val-Asp-difluorophenoxymethylketone (QVD-OPh) did not ( , and fig. S3, C and D).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration (Figure 4E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect (Figure 4E).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins (Figure 5K–S).

Biomarker Discovery:

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins ( K–S).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: In contrast, the BH3 mimetics ABT-737 and navitoclax were cytotoxic and did not confer functional benefits to eSCs.

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration ( E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect ( E).

Article Title: Differential regulation of BAX and BAK apoptotic activity revealed by small molecules
Article Snippet: In line with this, WEHI-3773 enabled long-term clonogenic survival of BAK −/− HeLa and BAK −/− HCT116 cell lines treated with BH3 mimetics ABT-737 and MCL-1 inhibitor S63845, whereas caspase inhibition with quinoline-Val-Asp-difluorophenoxymethylketone (QVD-OPh) did not ( , and fig. S3, C and D).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration (Figure 4E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect (Figure 4E).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins (Figure 5K–S).

Screening Assay:

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins ( K–S).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: In contrast, the BH3 mimetics ABT-737 and navitoclax were cytotoxic and did not confer functional benefits to eSCs.

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration ( E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect ( E).

Article Title: Differential regulation of BAX and BAK apoptotic activity revealed by small molecules
Article Snippet: In line with this, WEHI-3773 enabled long-term clonogenic survival of BAK −/− HeLa and BAK −/− HCT116 cell lines treated with BH3 mimetics ABT-737 and MCL-1 inhibitor S63845, whereas caspase inhibition with quinoline-Val-Asp-difluorophenoxymethylketone (QVD-OPh) did not ( , and fig. S3, C and D).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration (Figure 4E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect (Figure 4E).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins (Figure 5K–S).

Flow Cytometry:

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins ( K–S).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: In contrast, the BH3 mimetics ABT-737 and navitoclax were cytotoxic and did not confer functional benefits to eSCs.

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration ( E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect ( E).

Article Title: Differential regulation of BAX and BAK apoptotic activity revealed by small molecules
Article Snippet: In line with this, WEHI-3773 enabled long-term clonogenic survival of BAK −/− HeLa and BAK −/− HCT116 cell lines treated with BH3 mimetics ABT-737 and MCL-1 inhibitor S63845, whereas caspase inhibition with quinoline-Val-Asp-difluorophenoxymethylketone (QVD-OPh) did not ( , and fig. S3, C and D).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration (Figure 4E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect (Figure 4E).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins (Figure 5K–S).

Membrane:

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins ( K–S).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: In contrast, the BH3 mimetics ABT-737 and navitoclax were cytotoxic and did not confer functional benefits to eSCs.

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration ( E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect ( E).

Article Title: Differential regulation of BAX and BAK apoptotic activity revealed by small molecules
Article Snippet: In line with this, WEHI-3773 enabled long-term clonogenic survival of BAK −/− HeLa and BAK −/− HCT116 cell lines treated with BH3 mimetics ABT-737 and MCL-1 inhibitor S63845, whereas caspase inhibition with quinoline-Val-Asp-difluorophenoxymethylketone (QVD-OPh) did not ( , and fig. S3, C and D).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration (Figure 4E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect (Figure 4E).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins (Figure 5K–S).

Staining:

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins ( K–S).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: In contrast, the BH3 mimetics ABT-737 and navitoclax were cytotoxic and did not confer functional benefits to eSCs.

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration ( E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect ( E).

Article Title: Differential regulation of BAX and BAK apoptotic activity revealed by small molecules
Article Snippet: In line with this, WEHI-3773 enabled long-term clonogenic survival of BAK −/− HeLa and BAK −/− HCT116 cell lines treated with BH3 mimetics ABT-737 and MCL-1 inhibitor S63845, whereas caspase inhibition with quinoline-Val-Asp-difluorophenoxymethylketone (QVD-OPh) did not ( , and fig. S3, C and D).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration (Figure 4E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect (Figure 4E).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins (Figure 5K–S).

Colony Assay:

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins ( K–S).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: In contrast, the BH3 mimetics ABT-737 and navitoclax were cytotoxic and did not confer functional benefits to eSCs.

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration ( E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect ( E).

Article Title: Differential regulation of BAX and BAK apoptotic activity revealed by small molecules
Article Snippet: In line with this, WEHI-3773 enabled long-term clonogenic survival of BAK −/− HeLa and BAK −/− HCT116 cell lines treated with BH3 mimetics ABT-737 and MCL-1 inhibitor S63845, whereas caspase inhibition with quinoline-Val-Asp-difluorophenoxymethylketone (QVD-OPh) did not ( , and fig. S3, C and D).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration (Figure 4E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect (Figure 4E).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins (Figure 5K–S).

Western Blot:

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins ( K–S).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: In contrast, the BH3 mimetics ABT-737 and navitoclax were cytotoxic and did not confer functional benefits to eSCs.

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration ( E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect ( E).

Article Title: Differential regulation of BAX and BAK apoptotic activity revealed by small molecules
Article Snippet: In line with this, WEHI-3773 enabled long-term clonogenic survival of BAK −/− HeLa and BAK −/− HCT116 cell lines treated with BH3 mimetics ABT-737 and MCL-1 inhibitor S63845, whereas caspase inhibition with quinoline-Val-Asp-difluorophenoxymethylketone (QVD-OPh) did not ( , and fig. S3, C and D).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration (Figure 4E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect (Figure 4E).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins (Figure 5K–S).

Comparison:

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins ( K–S).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: In contrast, the BH3 mimetics ABT-737 and navitoclax were cytotoxic and did not confer functional benefits to eSCs.

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration ( E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect ( E).

Article Title: Differential regulation of BAX and BAK apoptotic activity revealed by small molecules
Article Snippet: In line with this, WEHI-3773 enabled long-term clonogenic survival of BAK −/− HeLa and BAK −/− HCT116 cell lines treated with BH3 mimetics ABT-737 and MCL-1 inhibitor S63845, whereas caspase inhibition with quinoline-Val-Asp-difluorophenoxymethylketone (QVD-OPh) did not ( , and fig. S3, C and D).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration (Figure 4E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect (Figure 4E).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins (Figure 5K–S).

Transduction:

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins ( K–S).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: In contrast, the BH3 mimetics ABT-737 and navitoclax were cytotoxic and did not confer functional benefits to eSCs.

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration ( E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect ( E).

Article Title: Differential regulation of BAX and BAK apoptotic activity revealed by small molecules
Article Snippet: In line with this, WEHI-3773 enabled long-term clonogenic survival of BAK −/− HeLa and BAK −/− HCT116 cell lines treated with BH3 mimetics ABT-737 and MCL-1 inhibitor S63845, whereas caspase inhibition with quinoline-Val-Asp-difluorophenoxymethylketone (QVD-OPh) did not ( , and fig. S3, C and D).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration (Figure 4E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect (Figure 4E).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins (Figure 5K–S).

Plasmid Preparation:

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins ( K–S).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: In contrast, the BH3 mimetics ABT-737 and navitoclax were cytotoxic and did not confer functional benefits to eSCs.

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration ( E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect ( E).

Article Title: Differential regulation of BAX and BAK apoptotic activity revealed by small molecules
Article Snippet: In line with this, WEHI-3773 enabled long-term clonogenic survival of BAK −/− HeLa and BAK −/− HCT116 cell lines treated with BH3 mimetics ABT-737 and MCL-1 inhibitor S63845, whereas caspase inhibition with quinoline-Val-Asp-difluorophenoxymethylketone (QVD-OPh) did not ( , and fig. S3, C and D).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration (Figure 4E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect (Figure 4E).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins (Figure 5K–S).

Concentration Assay:

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins ( K–S).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: In contrast, the BH3 mimetics ABT-737 and navitoclax were cytotoxic and did not confer functional benefits to eSCs.

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration ( E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect ( E).

Article Title: Differential regulation of BAX and BAK apoptotic activity revealed by small molecules
Article Snippet: In line with this, WEHI-3773 enabled long-term clonogenic survival of BAK −/− HeLa and BAK −/− HCT116 cell lines treated with BH3 mimetics ABT-737 and MCL-1 inhibitor S63845, whereas caspase inhibition with quinoline-Val-Asp-difluorophenoxymethylketone (QVD-OPh) did not ( , and fig. S3, C and D).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: Among the non-flavonoid senolytics, only dasatinib significantly suppressed eSC migration (Figure 4E), while the BH3 mimetics ABT-737 and navitoclax, at equivalent doses, showed no significant effect (Figure 4E).

Article Title: Targeting Cellular Senescence to Enhance Human Endometrial Stromal Cell Decidualization and Inhibit Their Migration
Article Snippet: The BH3 mimetics ABT-737 and navitoclax did not alter the expression of any of these signaling proteins (Figure 5K–S).



Similar Products

86
Mimetics bh3 mimetics abt 737
a. Gene ontology analysis of differentially expressed genes of HAP-1 cells after 24 h treatment with 50 nM of NoA or DMSO vehicle control. b. Schematic of mitochondrial apoptosis regulation by BCL-2 family members. Chronic cellular stress <t>BH3-only</t> proteins upregulation antagonize pro-survival BCL-2 members and activate BAX/BAK, resulting in mitochondrial outer membrane permeabilization and apoptosis. c. Heatmap showing regulation of canonical ATF4 target genes extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. d. Heatmap showing regulation of canonical JUN target genes extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. e. Heatmap showing regulation of pro-apoptotic BH-3 proteins extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. f. Western blot analysis of HAP-1 WT cells treated with 50 nM NoA. Cells were harvested at 0, 3, 6, 12 and 24 h after treatment, and protein lysates were probed with the indicated antibodies. g. Nalm-6 WT and KO clones were treated with 12, 25 and 50 nM of NoA. Annexin V surface binding and Propidium Iodide uptake was measured after 72 h to assess viability of the cells. Bar plots show mean ± SD of three biological replicates. Legend: AV−/PI− = live cells, AV+/PI− = early apoptosis, AV+/PI+ and AV−/PI+ = late apoptosis. Statistical significance was determined using a two-way ANOVA with Bonferroni correction for multiple comparisons, comparing percentages of live cells of corresponding concentrations between WT and KO clones. * P < 0.05, ** P < 0.005 h. Western blot analysis of Nalm-6 and HCT-116 WT cells treated with 50 nM NoA. Cells were harvested at 0, 12, 24 and 36 h after NoA treatment and protein lysates probed with indicated antibodies. MCL-1 OMM refers to the full-length, anti-apoptotic isoform MCL-1.
Bh3 Mimetics Abt 737, supplied by Mimetics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bh3+mimetics+abt-737/bh3+mimetics/bio_rxiv__64898__2026__03__27__714872-5-20-21
Average 86 stars, based on 1 article reviews
bh3 mimetics abt 737 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

90
Mimetics bh3 mimetics abt-737
a. Gene ontology analysis of differentially expressed genes of HAP-1 cells after 24 h treatment with 50 nM of NoA or DMSO vehicle control. b. Schematic of mitochondrial apoptosis regulation by BCL-2 family members. Chronic cellular stress <t>BH3-only</t> proteins upregulation antagonize pro-survival BCL-2 members and activate BAX/BAK, resulting in mitochondrial outer membrane permeabilization and apoptosis. c. Heatmap showing regulation of canonical ATF4 target genes extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. d. Heatmap showing regulation of canonical JUN target genes extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. e. Heatmap showing regulation of pro-apoptotic BH-3 proteins extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. f. Western blot analysis of HAP-1 WT cells treated with 50 nM NoA. Cells were harvested at 0, 3, 6, 12 and 24 h after treatment, and protein lysates were probed with the indicated antibodies. g. Nalm-6 WT and KO clones were treated with 12, 25 and 50 nM of NoA. Annexin V surface binding and Propidium Iodide uptake was measured after 72 h to assess viability of the cells. Bar plots show mean ± SD of three biological replicates. Legend: AV−/PI− = live cells, AV+/PI− = early apoptosis, AV+/PI+ and AV−/PI+ = late apoptosis. Statistical significance was determined using a two-way ANOVA with Bonferroni correction for multiple comparisons, comparing percentages of live cells of corresponding concentrations between WT and KO clones. * P < 0.05, ** P < 0.005 h. Western blot analysis of Nalm-6 and HCT-116 WT cells treated with 50 nM NoA. Cells were harvested at 0, 12, 24 and 36 h after NoA treatment and protein lysates probed with indicated antibodies. MCL-1 OMM refers to the full-length, anti-apoptotic isoform MCL-1.
Bh3 Mimetics Abt 737, supplied by Mimetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bh3+mimetics+abt-737/abt+737/us12351571-1456-15-12
Average 90 stars, based on 1 article reviews
bh3 mimetics abt-737 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


a. Gene ontology analysis of differentially expressed genes of HAP-1 cells after 24 h treatment with 50 nM of NoA or DMSO vehicle control. b. Schematic of mitochondrial apoptosis regulation by BCL-2 family members. Chronic cellular stress BH3-only proteins upregulation antagonize pro-survival BCL-2 members and activate BAX/BAK, resulting in mitochondrial outer membrane permeabilization and apoptosis. c. Heatmap showing regulation of canonical ATF4 target genes extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. d. Heatmap showing regulation of canonical JUN target genes extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. e. Heatmap showing regulation of pro-apoptotic BH-3 proteins extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. f. Western blot analysis of HAP-1 WT cells treated with 50 nM NoA. Cells were harvested at 0, 3, 6, 12 and 24 h after treatment, and protein lysates were probed with the indicated antibodies. g. Nalm-6 WT and KO clones were treated with 12, 25 and 50 nM of NoA. Annexin V surface binding and Propidium Iodide uptake was measured after 72 h to assess viability of the cells. Bar plots show mean ± SD of three biological replicates. Legend: AV−/PI− = live cells, AV+/PI− = early apoptosis, AV+/PI+ and AV−/PI+ = late apoptosis. Statistical significance was determined using a two-way ANOVA with Bonferroni correction for multiple comparisons, comparing percentages of live cells of corresponding concentrations between WT and KO clones. * P < 0.05, ** P < 0.005 h. Western blot analysis of Nalm-6 and HCT-116 WT cells treated with 50 nM NoA. Cells were harvested at 0, 12, 24 and 36 h after NoA treatment and protein lysates probed with indicated antibodies. MCL-1 OMM refers to the full-length, anti-apoptotic isoform MCL-1.

Journal: bioRxiv

Article Title: Inhibition of V-ATPase function drives apoptosis via GCN1/GCN2 kinase signaling

doi: 10.64898/2026.03.27.714872

Figure Lengend Snippet: a. Gene ontology analysis of differentially expressed genes of HAP-1 cells after 24 h treatment with 50 nM of NoA or DMSO vehicle control. b. Schematic of mitochondrial apoptosis regulation by BCL-2 family members. Chronic cellular stress BH3-only proteins upregulation antagonize pro-survival BCL-2 members and activate BAX/BAK, resulting in mitochondrial outer membrane permeabilization and apoptosis. c. Heatmap showing regulation of canonical ATF4 target genes extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. d. Heatmap showing regulation of canonical JUN target genes extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. e. Heatmap showing regulation of pro-apoptotic BH-3 proteins extracted from the RNA-seq data. Values show row scaled vst-normalized expression of differentially expressed genes. Values of n=4 technical replicates are shown. f. Western blot analysis of HAP-1 WT cells treated with 50 nM NoA. Cells were harvested at 0, 3, 6, 12 and 24 h after treatment, and protein lysates were probed with the indicated antibodies. g. Nalm-6 WT and KO clones were treated with 12, 25 and 50 nM of NoA. Annexin V surface binding and Propidium Iodide uptake was measured after 72 h to assess viability of the cells. Bar plots show mean ± SD of three biological replicates. Legend: AV−/PI− = live cells, AV+/PI− = early apoptosis, AV+/PI+ and AV−/PI+ = late apoptosis. Statistical significance was determined using a two-way ANOVA with Bonferroni correction for multiple comparisons, comparing percentages of live cells of corresponding concentrations between WT and KO clones. * P < 0.05, ** P < 0.005 h. Western blot analysis of Nalm-6 and HCT-116 WT cells treated with 50 nM NoA. Cells were harvested at 0, 12, 24 and 36 h after NoA treatment and protein lysates probed with indicated antibodies. MCL-1 OMM refers to the full-length, anti-apoptotic isoform MCL-1.

Article Snippet: Loss of MCL-1 creates a vulnerability that renders cells dependent on co-expressed BCL-2 family proteins, enabling potent synergy with the BH3 mimetics ABT-737 or venetoclax.

Techniques: Control, Membrane, RNA Sequencing, Expressing, Western Blot, Clone Assay, Binding Assay

a. Bottom: Representative cell cycle profiles of HAP-1 WT and BB dKO cells after exposure to 12.5, 25 and 50 nM of NoA. Right: Ǫuantification of the SubG1 population represented as bar graphs, showing means and SD of N=3 biological replicates. Statistical significance was determined using a two-way ANOVA with Bonferroni correction for multiple comparisons, comparing SubG1 percentages of corresponding concentrations of WT with BBdKO cells at every time point. **** P < 0.0001 b. HAP-1 WT and HAP-1 BB dKO KO cells were treated with 12.5, 25 and 50 nM of BafA1. Annexin V surface binding and Propidium Iodide uptake was measured after 48 and 72 h to assess viability of the cells. Bar plots show mean ± SD of three biological replicates. Legend: AV−/PI− = live cells, AV+/PI− = early apoptosis, AV+/PI+ and AV−/PI+ = late apoptosis. Statistical significance was determined using a two-way ANOVA with Bonferroni correction for multiple comparisons, comparing percentages of live cells of corresponding concentrations between WT and BB dKO cells at every time point. **** P < 0.0001. c. WB analysis of HAP-1 WT, GCN1 KO, and GCN2 KO cells treated with NoA or BafA1 (25 or 50 nM) for 24 h. Cell lysates were probed for the indicated proteins. d. HAP-1 WT and GCN1 KO cells were treated with BafA1 (6.25, 12.5, 25, or 50 nM). HAP-1 WT cells were treated either with BafA1 alone or in combination with the GCN2 inhibitor GCN2iB (10 μM). Annexin V surface binding and propidium iodide (PI) uptake were measured after 48 and 72 h to assess cell viability. Bar plots represent mean ± SD of three biological replicates. Legend: AV−/PI−, live cells; AV+/PI−, early apoptosis; AV+/PI+ and AV−/PI+, late apoptosis. Statistical significance was determined by two-way ANOVA with Bonferroni correction for multiple comparisons, comparing percentages of live cells at corresponding concentrations between WT and GCN1 KO cells or WT cells co-treated with GCN2iB at each time point. ** P < 0.01, *** P < 0.001, ** P < 0.0001. e. HCT-116 WT and Octa KO clones were treated with 12.5, 25 and 5 0nM of BafA1. Annexin V surface binding and Propidium Iodide uptake was measured after 24, 48 and 72 h to assess cell viability. Bar plots show mean ± SD of three biological replicates. Legend: AV−/PI− = live cells, AV+/PI− = early apoptosis, AV+/PI+ and AV−/PI+ = late apoptosis. Statistical significance was determined using a two-way ANOVA with Bonferroni correction for multiple comparisons, comparing percentages of live cells of corresponding concentrations between WT and Octa KO clones. * P < 0.015, ** P < 0.004, *** P < 0.001, **** P < 0.0001 f. HAP-1 WT cells were treated with indicated V-ATPase inhibitors (25 nM) or ABT-737 (1 μM) alone or in combination for 24 h. Viability was assessed by Annexin V surface binding and Propidium Iodide uptake. Viable fraction was defined as double negative cells and is depicted as mean ± SD of three biological replicates. g. Dot plot showing synergy scores for combinations of V-ATPase inhibitors with BH3 mimetics (ABT-737 and ABT-199). Synergy scores were calculated using the SynergyFinder web tool based on concentration matrices of two biological replicates. Cell viability was defined as the fraction of Annexin V−/PI− (double-negative) cells, representing live cells. h. Proposed mechanism for V-ATPase inhibition induced cell death

Journal: bioRxiv

Article Title: Inhibition of V-ATPase function drives apoptosis via GCN1/GCN2 kinase signaling

doi: 10.64898/2026.03.27.714872

Figure Lengend Snippet: a. Bottom: Representative cell cycle profiles of HAP-1 WT and BB dKO cells after exposure to 12.5, 25 and 50 nM of NoA. Right: Ǫuantification of the SubG1 population represented as bar graphs, showing means and SD of N=3 biological replicates. Statistical significance was determined using a two-way ANOVA with Bonferroni correction for multiple comparisons, comparing SubG1 percentages of corresponding concentrations of WT with BBdKO cells at every time point. **** P < 0.0001 b. HAP-1 WT and HAP-1 BB dKO KO cells were treated with 12.5, 25 and 50 nM of BafA1. Annexin V surface binding and Propidium Iodide uptake was measured after 48 and 72 h to assess viability of the cells. Bar plots show mean ± SD of three biological replicates. Legend: AV−/PI− = live cells, AV+/PI− = early apoptosis, AV+/PI+ and AV−/PI+ = late apoptosis. Statistical significance was determined using a two-way ANOVA with Bonferroni correction for multiple comparisons, comparing percentages of live cells of corresponding concentrations between WT and BB dKO cells at every time point. **** P < 0.0001. c. WB analysis of HAP-1 WT, GCN1 KO, and GCN2 KO cells treated with NoA or BafA1 (25 or 50 nM) for 24 h. Cell lysates were probed for the indicated proteins. d. HAP-1 WT and GCN1 KO cells were treated with BafA1 (6.25, 12.5, 25, or 50 nM). HAP-1 WT cells were treated either with BafA1 alone or in combination with the GCN2 inhibitor GCN2iB (10 μM). Annexin V surface binding and propidium iodide (PI) uptake were measured after 48 and 72 h to assess cell viability. Bar plots represent mean ± SD of three biological replicates. Legend: AV−/PI−, live cells; AV+/PI−, early apoptosis; AV+/PI+ and AV−/PI+, late apoptosis. Statistical significance was determined by two-way ANOVA with Bonferroni correction for multiple comparisons, comparing percentages of live cells at corresponding concentrations between WT and GCN1 KO cells or WT cells co-treated with GCN2iB at each time point. ** P < 0.01, *** P < 0.001, ** P < 0.0001. e. HCT-116 WT and Octa KO clones were treated with 12.5, 25 and 5 0nM of BafA1. Annexin V surface binding and Propidium Iodide uptake was measured after 24, 48 and 72 h to assess cell viability. Bar plots show mean ± SD of three biological replicates. Legend: AV−/PI− = live cells, AV+/PI− = early apoptosis, AV+/PI+ and AV−/PI+ = late apoptosis. Statistical significance was determined using a two-way ANOVA with Bonferroni correction for multiple comparisons, comparing percentages of live cells of corresponding concentrations between WT and Octa KO clones. * P < 0.015, ** P < 0.004, *** P < 0.001, **** P < 0.0001 f. HAP-1 WT cells were treated with indicated V-ATPase inhibitors (25 nM) or ABT-737 (1 μM) alone or in combination for 24 h. Viability was assessed by Annexin V surface binding and Propidium Iodide uptake. Viable fraction was defined as double negative cells and is depicted as mean ± SD of three biological replicates. g. Dot plot showing synergy scores for combinations of V-ATPase inhibitors with BH3 mimetics (ABT-737 and ABT-199). Synergy scores were calculated using the SynergyFinder web tool based on concentration matrices of two biological replicates. Cell viability was defined as the fraction of Annexin V−/PI− (double-negative) cells, representing live cells. h. Proposed mechanism for V-ATPase inhibition induced cell death

Article Snippet: Loss of MCL-1 creates a vulnerability that renders cells dependent on co-expressed BCL-2 family proteins, enabling potent synergy with the BH3 mimetics ABT-737 or venetoclax.

Techniques: Binding Assay, Clone Assay, Concentration Assay, Inhibition